ITGAE and allergic asthma: We found a lack of CD103 lead to significantly reduced clinical symptoms of EAAD, including reduced AHR and airway eosinophilia, when compared to wild‐type (WT) BALB/c mice, suggesting a pathogenic role for CD103 in the pathogenesis of allergic asthma in this model.